métodos estadísticos en el trasplante renal - Roche Trasplantes

More documents

Recommendations

Info

RESULTADOS DEL TRASPLANTE RENAL: ENSAYOS CLÍNICOS Y REGISTROS27. Kaplan B, Schold J, Meier-Kriesche H-U. Overview of large database analysis in renaltransplantation. Am J Transplant 2003; 3: 1052-6.28. Fernández M, Abraira V, Quereda C, Ortuño J. Curvas de supervivencia y modelosde regresión: errores y aciertos en la metodología de aplicación. Nefrología 1996;16: 383-90.29. Klabunde CN, Warren JL, Legler JM. Assesing comorbidity using claims data. MedCare 2002; 40 (Suppl.): IV26-IV35.30. Schneeweiss S, Seeger JD, Maclure M, Wang PS, Avorn J, Glynn RL. Performanceof comorbidity scores to control for confounding in epidemiologic studies usingclaims data. Am J Epidemiol 2001; 154: 854-64.31. Schneeweiss S, Maclure M. Use of comorbidity scores for control of confounding instudies using administrative databases. Int J Epidemiol 2000; 29: 891-8.32. Hutchinson TA, Thomas DC, MacGibbon B. Predicting survival in adults with end-stagerenal disease: an age equivalence index. Ann Intern Med 1982; 96: 417-23.33. Charlson ME, Pompei P, Ales KL, MacKenzie CR. A new method of classifying prognosticcomorbidity in longitudinal studies: development and validation J Chron Dis1987; 40: 373-83.34. Khan IH, Catto GRD, Edward N, Fleming LW, Henderson IS, MacLeod AM.Influence of coexisting disease on survival on renal-replacement therapy. Lancet1993; 341: 415-8.35. Beddhu S, Zeidel ML, Saul M, Seddon P, Samore MH, Stoddard GJ, Bruns FJ. Theeffects of comorbid conditions on the outcomes of patients undergoing peritonealdialysis. Am J Med 2002; 112: 696-701.36. Van Manen JG, Korevaar JC, Dekker FW, Boeschoten EW, Bossuyt PMM, KredietRT. How to adjust for comorbidity in survival studies in ESRD patients: a comparisonof different indices. Am J Kidney Dis 2002; 40: 82-9.37. Lash TL, Thwin SS, Horton NJ, Guadagnoli E, Silliman RA. Multiple informants: anew method to assess breast cancer patient´s comorbidity. Am J Epidemiol 2003;157: 249-57.197
Page 1 and 2:
B i b l i o t e c a d eT R A S P L
Page 3 and 4:
DRUGEdificio Vértice Antonio Lópe
Page 6:
Electronic Control Device Research
Page 10 and 11:
MÉTODOS ESTADÍSTICOS EN EL TRASPL
Page 12 and 13:
Page 14 and 15:
Page 16 and 17:
Page 18 and 19:
Page 20 and 21:
Page 22 and 23:
Page 24 and 25:
Page 26 and 27:
Page 29:
ESTADÍSTICA EN BIOMEDICINA: UNA HE
Page 32 and 33:
Page 34 and 35:
Page 36 and 37:
Page 38 and 39:
Page 40 and 41:
Page 42 and 43:
Page 44 and 45:
Page 46 and 47:
Page 48 and 49:
Page 50 and 51:
Page 52 and 53:
Page 54 and 55:
Page 56 and 57:
Page 58 and 59:
Page 60 and 61:
Page 62 and 63:
Page 64 and 65:
Page 66 and 67:
EL CONCEPTO DE SEMIVIDACOMO PREDICT
Page 68 and 69:
EL CONCEPTO SEMIVIDA COMO PREDICTOR
Page 70 and 71:
Page 72 and 73:
Page 74 and 75:
Page 76 and 77:
Page 78 and 79:
Page 80 and 81:
Page 82 and 83:
Page 84 and 85:
Page 86 and 87:
Page 88 and 89:
Page 90 and 91:
Page 92 and 93:
Page 94 and 95:
Page 96 and 97:
Page 98 and 99:
Page 100 and 101:
Page 102 and 103:
Page 104 and 105:
Page 106 and 107:
Page 108 and 109:
Page 110 and 111:
Page 112 and 113:
Page 114 and 115:
Page 116 and 117:
Page 118 and 119:
Page 120 and 121:
Page 122 and 123:
Page 124 and 125:
Page 126 and 127:
Page 128 and 129:
Page 130 and 131:
Page 132 and 133:
Page 134 and 135:
Page 136 and 137:
Page 138 and 139:
Page 140 and 141:
Page 142 and 143:
Page 144 and 145: MÉTODOS ESTADÍSTICOS EN EL TRASPL
Page 146 and 147: DE LAS BASES DE DATOSA LOS PROGRAMA
Page 148 and 149: DE LAS BASES DE DATOS A LOS PROGRAM
Page 160 and 161: RESULTADOS DEL TRASPLANTERENAL: ENS
Page 162 and 163: RESULTADOS DEL TRASPLANTE RENAL: EN
show all

métodos estadísticos en el trasplante renal - Roche Trasplantes

Create successful ePaper yourself

Delete template?

Save as template?